Our previously identified candidate PCa‐EV biomarkers XPO1 (P < 0.0001) and FASN (P < 0.0001) were higher expressed in PCa tissue, while PDCD6IP was borderline not significantly higher expressed (P = 0.0501) (Table 1; Figure 1B). The gene discussed is FASN; the disease is posterior cortical atrophy.